“Addition of Daratumumab to First-Line Therapy of Newly Diagnosed Multiple Myeloma in Patients Eligible for Autologous Stem Cell Transplantation: A Single-Center Real-Life Experience”. 2025. Mediterranean Journal of Hematology and Infectious Diseases 17 (1): e2025040. https://doi.org/10.4084/MJHID.2025.040.